Goodyer Paul
Department of Pediatrics, McGill University, Montreal, QC, Canada H3H 1P3.
Int J Nephrol. 2011;2011:929456. doi: 10.4061/2011/929456. Epub 2011 Oct 13.
Cystinosis is a rare disorder, and, accordingly, progress on the understanding and treatment of this disease has been relatively slow. Although cystinosis was identified over 100 years ago, the history of cystinosis is marked by a few sudden leaps forward in our understanding rather than by a sustained research effort fuelled by the larger research community. Major conceptual break-throughs include (a) its discovery in 1903, (b) recognition of the renal Fanconi syndrome, (c) realization that tissue accumulation of cystine reflects a defective channel in the lysosomal membrane, (d) translation of this discovery to trials of cysteamine, (e) discovery of the CTNS gene, and (f) report of successful stem cell therapy in the cystinotic mouse. This paper focuses on the importance management lessons from these milestones and the potential new therapeutic strategies which may be looming in the near future.
胱氨酸病是一种罕见疾病,因此,在对该疾病的认识和治疗方面进展相对缓慢。尽管胱氨酸病在100多年前就已被发现,但其历史的特点是在我们的认识上有几次突然的飞跃,而不是由更大的研究群体推动的持续研究努力。主要的概念突破包括:(a)1903年对其的发现;(b)对肾性范科尼综合征的认识;(c)意识到胱氨酸在组织中的积累反映了溶酶体膜上的一个缺陷通道;(d)将这一发现转化为半胱胺试验;(e)CTNS基因的发现;以及(f)胱氨酸病小鼠成功进行干细胞治疗的报告。本文重点关注这些里程碑事件中的重要管理经验教训以及近期可能出现的潜在新治疗策略。